Omaveloxolone
Commons · Question 29915 · Tabled 15 Sep 2026 · Department of Health and Social Care · Official record
Awaiting answer, due 12 Oct 2026
Question
Asked by Jim Shannon
To ask the Secretary of State for Health and Social Care, what discussions her Department has had with Biogen regarding the company's withdrawal of its evidence submission to NICE for the appraisal of omaveloxolone for the treatment of Friedreich's ataxia